Abstract: A multi-stage adjusting damping valve as well as a shock absorber and suspension system using the damping valve are provided. The multi-stage adjusting damping valve comprises a throttle valve, an overflow valve and a multi-stage pilot valve. The multi-stage pilot valve comprises a mechanical regulating valve and a plurality of high-speed switch electromagnetic valves having different throttle hole diameters. The damping valve is connected between a rod cavity and an oil storage cavity of the shock absorber by means of a middle cavity, and the multi-stage damping rapid regulation of the shock absorber is achieved through high-frequency opening and closing of a high-speed switching electromagnetic valve, and in comparison, the machining precision, the manufacturing cost and the control and calibration difficulty of the present disclosure are greatly reduced.

Abstract: The present invention provides a composition comprising a compound of formula (I) or a physiologically acceptable salt thereof, in which the compound of formula (I) or a physiologically acceptable salt thereof has a HPLC purity of ?90%; wherein R1, R2, X and n are as defined herein. The present invention further provides use of the composition according to the present invention for preparing and/or purifying a composition comprising a salt of the compound of formula (I), and a method for treating a disease caused by a coronavirus which comprises administering the composition of the present invention to a subject. The composition of the present invention comprises the compound of formula (I) with high purity, and has good fluidity and anti-caking property; moreover, the claimed composition comprising the compound of formula (I)) with high purity is more suitable for preparing a composition comprising a salt of the compound of formula (I) with higher purity.

Abstract: A session border controller (SBC) system includes an SBC signaling and media processing module and an SBC signaling access module. The SBC signaling access module is configured to: receive signaling sent by a terminal and forward the signaling to the SBC signaling and media processing module; and when the terminal is disconnected from a network during a call, re-register and reconnect the terminal, and after the terminal is reconnected, receive an information request from the terminal during the call and forward the information request to the SBC signaling and media processing module. The SBC signaling and media processing module is configured to: process the signaling and media streams from the terminal, and when the terminal is disconnected from the network during the call, learn, based on the information request, a transmission link for communication with the terminal after the terminal is reconnected upon the disconnection from the network.

Abstract: An IV access device can include a needle hub that incorporates a flash chamber. The flash chamber can be used to provide visual confirmation of proper catheter placement within a vein. The flash chamber can include a path-defining structure to facilitate identifying whether blood is continually flowing into the flash chamber. The flash chamber may also be removable from the needle hub. In some cases, the needle hub may include a paddle grip that facilitates insertion of the catheter and separation of the needle hub from the catheter adapter.

Abstract: The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof: which inhibit the Apoptosis signal-regulating kinase 1 (ASK-1), which is associated with autoimmune disorders, neurodegenerative disorders, inflammatory diseases, chronic kidney disease, cardiovascular disease. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from ASK-1 related disease. The invention also relates to methods of treating an ASK-1 related disease in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention specifically relates to methods of treating ASK-1 associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Abstract: A method for semantic recognition includes: in response to performing semantic analysis on information acquired by a terminal, a sentence to be processed is acquired. Word recognition is performed on the sentence to be processed, to obtain a plurality of words and part-of-speech information thereof. A target set update operation is determined with a pre-trained word processing model, according to a word to be processed in the set of words to be processed and part-of-speech information of the word to be processed. If a dependency relationship corresponding to the target set update operation is a first dependency relationship, through each of the plurality of preset set update operations, a respective dependency relationship of the word to be processed and a respective confidence level corresponding to the dependency relationship is determined, and a respective update of the set of words to be processed is performed.

Abstract: A method for dispatching a power grid is disclosed. The method includes: obtaining a whole power generation interval scheduled for a cluster of renewable energy stations from a power grid dispatching center; establishing a decomposition model that includes an objection function and constraint conditions; decomposing the whole power generation interval with the decomposition model to obtain each power generation interval of each renewable energy station; and controlling each renewable energy station to generate powers based on each power generation interval. The objection function minimizes a total operating cost in the power grid and includes a renewable energy randomness indicating an actual power generation amount of each renewable energy station.

Abstract: Disclosed in the present invention are a method and apparatus for automatically improving printing effect, a device, and a storage medium. The method comprises: receiving an import request of a 3D model, and parsing a triangle patch comprised in the 3D model; acquiring all angular points of the 3D model according to the triangle patch, subtracting a minimum angular point from a maximum angular point to obtain a bounding box of the 3D model, creating an axis perpendicular to the bounding box; using the axis and a platform inclination angle to calculate a quaternion related to the rotation of the 3D model; multiplying a space matrix of the bounding box of the 3D model by the rotation matrix, enabling a printing path to be perpendicular to the bounding box. The model is imported to automatically keep the inclination angle consistent with a platform, thereby improving the printing effect.

Abstract: The present invention provides a drive module for a GaN transistor, including: a first pull-down transistor and a gate ringing and overshoot suppression unit, where the gate ringing and overshoot suppression unit and a first end of the first pull-down transistor are directly or indirectly connected to a gate of the GaN transistor, the gate ringing and overshoot suppression unit is connected between a second end of the first pull-down transistor and the ground; the gate ringing and overshoot suppression unit is configured to: when a gate voltage of the GaN transistor drops, control the release of a gate charge of the GaN transistor with a first impedance if the gate voltage is higher than a specified threshold; and control the release of the gate charge of the GaN transistor with a second impedance if the gate voltage is less than the specified threshold, where the first impedance is less than the second impedance.

Abstract: An apparatus can include a touch-up component. The touch-up component can detect that at least one memory cell of a page of memory cells has lost a portion of a charge. The touch-up component can set touch-up parameters for the page of memory cells. The touch-up component can cause a transfer of data from the page of memory cells to a cache. The touch-up component can reprogram the at least one memory cell using the set touch-up parameters.

Abstract: The present invention relates to a preparation method of a BOPP film stiffening agent, including: taking cyclopentadiene or a derivative thereof and a norbornene monomer or C8 cycloolefin as a polymerization raw material, obtaining a polymerization resin liquid by continuous high-temperature polymerization, then preparing high-softening-point aliphatic hydrogenation petroleum resin through two-stage catalytic hydrogenation reaction and removing low-boiling-point light components and solvents; and then obtaining the BOPP film stiffening agent by mixing and extruding with homo-polypropylene. The stiffening agent prepared by the present invention has a very good anti-dissolution performance and environmental protection performance which is suitable for modification of a BOPP cigarette film, and has good market application prospects.

Abstract: The present invention discloses a method and apparatus for recommending user preferences based on neural set operations, wherein on the basis of obtaining a positive feedback interaction sequence and a negative feedback interaction sequence and user global preference information, a sequence of positive feedback interaction vectors and a sequence of negative feedback interaction vectors corresponding to the positive feedback interaction sequence and the negative feedback interaction sequence are simultaneously combined, and the positive feedback preference representation and the negative feedback preference representation are obtained using the ensemble operation.

Abstract: A method may include priming a catheter system. The catheter system may include a catheter adapter, a catheter, and an extension tube. The catheter system may also include a Y-adapter, which may include first and second arms. A distal end of the Y-adapter may be coupled to the extension tube. The catheter system may further include a vent cap, which may be coupled to the second arm. Priming the catheter system may include attaching an IV line to the first arm and delivering saline through the IV line to the catheter system such that the saline exits a distal tip of the catheter and clamping the IV line via a roller clamp on the IV line. The method may also include actuating the vent cap after priming the catheter system. The method may further include inserting the catheter into a vein of a patient after actuating the vent cap.

Abstract: An apparatus for page-copy data accessing is provided, which includes a memory cell array, bit-line sense-amplifier/buffers (BLSABFs), page buffers and a logic operation processing circuit. Data voltage signals on bit-lines in a memory section are transferred to the bit-lines in an adjacent memory section adjacent to the memory section by BLSABFs and the voltage data signals are sequentially propagated across subsequent memory sections through BLSABFs between the subsequent memory sections. The scheme can be applied as a method of page-data write access in a memory chip, of which page data can be propagated sequentially from section to subsequent adjacent section until a target location is reached, and then, activating a word line in a section of the memory comprising target location to write voltages to the memory cells at the target location. The page buffers are configured to receive data voltage signals from the coupled BLSABFs to a data interface.

Abstract: The present invention provides a composition comprising a compound of formula (I) or a physiologically acceptable salt thereof, in which the compound of formula (I) or a physiologically acceptable salt thereof has a HPLC purity of ? 90%; wherein R1, R2, X and n are as defined herein. The present invention further provides use of the composition according to the present invention for preparing and/or purifying a composition comprising a salt of the compound of formula (I), and a method for treating a disease caused by a coronavirus which comprises administering the composition of the present invention to a subject. The composition of the present invention comprises the compound of formula (I) with high purity, and has good fluidity and anti-caking property; moreover, the claimed composition comprising the compound of formula (I)) with high purity is more suitable for preparing a composition comprising a salt of the compound of formula (I) with higher purity.

Abstract: A bit allocation method and apparatus for an audio object are disclosed, which relate to the field of audio encoding and decoding technologies. The method includes: separately pre-rendering a plurality of audio objects to be pre-rendered in an audio frame, to obtain a plurality of pre-rendered audio objects; obtaining respective perceptual importance parameter values of the plurality of pre-rendered audio objects; obtaining a bit allocation parameter value of a current audio object to be pre-rendered based on the respective perceptual importance parameter values of the plurality of pre-rendered audio objects; and determining, based on the bit allocation parameter value of the current audio object to be pre-rendered and a total quantity of to-be-allocated bits corresponding to the plurality of audio objects to be pre-rendered, a target quantity of bits allocated to the current audio object to be pre-rendered.

Abstract: The present disclosure provides a crystal form comprising a compound of Formula (I) and fumaric acid, wherein the crystal form satisfies at least one of the following conditions: (1) a particle size D90 of the active pharmaceutical ingredient ranges from about 5 ?m to about 60 ?m; and (2) a particle size D50 of the active pharmaceutical ingredient does not exceed about 30 ?m; a pharmaceutical composition containing the crystal form, and a method for treating coronavirus-induced diseases by using the crystal form. The crystal form of the present disclosure enables the pharmaceutical composition containing the crystal form to have advantages such as a higher dissolution rate, a higher dissolution, and the like.

Abstract: An IV device assembly may include a lumen forming a fluidic channel within the IV device assembly. The lumen may be fluidically coupled to a vascular access device (VAD) coupler via a funnel coupler, and an IV device assembly coupler at a proximal end of the lumen. The IV device assembly may also include one or more of the following: a collapsible sleeve formed coaxially around a first portion of the lumen and mechanically coupled to the funnel coupler, a patency instrument formed along a second portion of the lumen within the collapsible sleeve and into the VAD coupler, a translation handle that translates the patency instrument out of a distal end of the VAD coupler, and a fixed grip formed around the lumen to maintain a position of the IV device assembly relative to the translation handle.

Abstract: The present invention relates to the technical field of medicines, and relates to a polyethylene glycol conjugated drug, a preparation method therefor and the use thereof. In particular, the present invention relates to a polyethylene glycol conjugated drug as shown in formula I or a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the polyethylene glycol conjugated drug or the pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug.

Abstract: Provided are methods for treating macular degeneration, optionally macular degeneration, in subject in need thereof. In some embodiments, the methods include administering to a subject in need thereof a therapeutically effective amount of fluoxetine in an amount and via a route sufficient to treat or prevent development of macular degeneration in the subjects. Also provided are methods for inhibiting activation of an NLRP3-ASC inflammasome in the subjects, inhibiting ASC speck formation in the subjects, inhibiting Alu RNA-induced RPE degeneration in the subjects, and treatment and/or prevention of the development of diseases, disorders, and/ or conditions.